Compass Increases Confidence in a 2-km Structural Gold Target Within 10-km Tarabala Trend
TORONTO, June 15, 2020 (GLOBE NEWSWIRE) — Compass Gold Corp. (TSX-V: CVB) (Compass or the Company) is pleased to provide […]
Auxly’s Joint Venture Partner, Sunens Farms, Receives Cultivation Licence at Large-Scale Facility
TORONTO, June 15, 2020 (GLOBE NEWSWIRE) — Auxly Cannabis Group Inc. (TSX.V – XLY) (“Auxly” or the “Company”), a consumer packaged goods […]
Medley Capital Corporation Subject to Monthly Expense Support, Houlihan Lokey Commenced Strategic Review Process
NEW YORK, June 15, 2020 (GLOBE NEWSWIRE) — Medley Capital Corporation (NYSE: MCC) (TASE: MCC) (the “Company”) announced today that, […]
Repligen Appoints Carrie Eglinton Manner to Board of Directors
WALTHAM, Mass., June 15, 2020 (GLOBE NEWSWIRE) — Repligen Corporation (NASDAQ:RGEN) today announced the appointment of healthcare industry executive Carrie […]
Vaxart, Inc. Appoints New CEO to Accelerate Advancement of COVID-19 and Other Programs
Andrei Floroiu Appointed Chief Executive OfficerWouter Latour, MD, to Continue as Chairman of the BoardSOUTH SAN FRANCISCO, Calif., June 15, […]
ContraFect Announces Appointment of Lishan Aklog, M.D. to Board of Directors
YONKERS, N.Y., June 15, 2020 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and […]
Marinus Pharmaceuticals Appoints Martha Manning as Vice President, General Counsel and Secretary
RADNOR, Pa., June 15, 2020 (GLOBE NEWSWIRE) — Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of […]
Venus Concept Inc. Announces FDA 510(k) Clearance for Venus Epileve
TORONTO, June 15, 2020 (GLOBE NEWSWIRE) — Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology […]
Bellicum Receives FDA IND Clearance to Initiate a Phase 1/2 Clinical Trial for BPX-603, a Dual-Switch GoCAR-T® for HER2+ Solid Tumors
HOUSTON, June 15, 2020 (GLOBE NEWSWIRE) — Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for […]
Genocea Files IND Application for GEN-011, a T cell Therapy Designed to Improve on Current Limitations of TIL Therapy
CAMBRIDGE, Mass., June 15, 2020 (GLOBE NEWSWIRE) — Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, today [...]
